{
  "scenario_id": "pharmaceuticals_drug_approval_2025",
  "decision_date": "2025-09-15",
  "context": "Pharmaceutical company evaluating FDA approval pathway for new oncology drug",
  "stakeholders": {
    "requester": "Chief Scientific Officer",
    "approvers": ["CEO", "Chief Medical Officer", "General Counsel"],
    "influencers": ["VP Regulatory Affairs", "VP Commercial", "Head of R&D"]
  },
  "request": {
    "amount": "$150M",
    "purpose": "Phase 3 clinical trial and FDA submission",
    "urgency": "high",
    "justification": "Market opportunity in unmet cancer treatment need"
  },
  "decision_process": [
    {
      "stage": "initial_review",
      "start_date": "2025-08-01",
      "end_date": "2025-08-15",
      "duration": "15 days",
      "activities": ["Scientific review", "Regulatory assessment", "Market analysis"],
      "outcome": "Advanced to full evaluation"
    },
    {
      "stage": "due_diligence",
      "start_date": "2025-08-16",
      "end_date": "2025-09-01",
      "duration": "17 days",
      "activities": ["Clinical data review", "Risk assessment", "Financial modeling"],
      "outcome": "Approved with conditions"
    },
    {
      "stage": "final_approval",
      "start_date": "2025-09-02",
      "end_date": "2025-09-15",
      "duration": "14 days",
      "activities": ["Board presentation", "Executive committee review", "Final vote"],
      "outcome": "Approved"
    }
  ],
  "business_impact": {
    "expected_outcome": "Launch of breakthrough cancer therapy",
    "projected_value": "$500M",
    "actual_value": "$0 (pending approval)",
    "roi_timeline": "5 years",
    "risk_factors": ["Clinical trial failure", "Regulatory rejection", "Market competition"]
  },
  "decision_criteria": ["Scientific merit", "Commercial potential", "Regulatory pathway", "Financial viability"],
  "outcome": "Approved",
  "implementation_timeline": {
    "start_date": "2025-10-01",
    "completion_date": "2030-09-30",
    "milestones": ["Phase 3 start: 2025-10-01", "FDA submission: 2028-06-01", "Launch: 2030-01-01"]
  },
  "outcome_tracking": {
    "6_month_review": "Clinical trial progress assessment",
    "12_month_review": "Regulatory feedback and market analysis",
    "actual_roi": "Pending clinical outcomes"
  },
  "lessons_learned": "Enhanced due diligence process improved decision quality"
}